Back to SGMT
MARSHALL WACE, LLP SGMT Position History
Sagimet Biosciences Inc. • Healthcare
Quarters held
14
Latest value
$2.9M
Q3 2026
Peak value
$4.2M
First seen
Q4 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2023 | $91K |
| Q1 2024 | $193K |
| Q3 2024 | $266K |
| Q3 2024 | $464K |
| Q4 2024 | $21K |
| Q4 2024 | $896K |
| Q1 2025 | $73K |
| Q4 2025 | $767K |
| Q4 2025 | $3.9M |
| Q1 2026 | $951K |
| Q1 2026 | $4.1M |
| Q3 2026 | $260K |
| Q3 2026 | $4.2M |
| Q3 2026 | $2.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $2.9M | 296.8K | — | — |
| Q3 2026 | $4.2M | 429.2K | — | — |
| Q3 2026 | $260K | 26.4K | — | — |
| Q1 2026 | $4.1M | 784.1K | — | — |
| Q1 2026 | $951K | 182.1K | — | — |
| Q4 2025 | $3.9M | 650.8K | — | — |
| Q4 2025 | $767K | 129.6K | — | — |
| Q1 2025 | $73K | 22.3K | — | — |
| Q4 2024 | $896K | 199.2K | — | — |
| Q4 2024 | $21K | 4.6K | — | — |
| Q3 2024 | $464K | 167.7K | — | — |
| Q3 2024 | $266K | 95.9K | — | — |
| Q1 2024 | $193K | 35.7K | — | — |
| Q4 2023 | $91K | 16.8K | — | — |